Abstract:
The 
MATERIALS AND METHODS
Animals and treatment: Fortyfour male albino rats of ITRC colony weighing 160 ± 10 g, maintained on pellet diet (Hind Lever Ltd., India) and water ad libitum were divided into three groups. Eighteen animals in each of groups I and II were injected 0.076 m mole (4 mg) /Kg, Cr as chromium nitrate [Cr (NO3)3. 9H2O] (Cr+3) or as potassium chromate [K2CrO4] (Cr+6) dissolved in normal saline, intraperitoneally, daily for two weeks. Eight animals in group III received an equal volume of saline only, which served as control. Six animals from groups I and II and two from group III were sacrificed by decapitation after 1,7 and 14 injections. Liver and kidneys were removed and washed free of extraneous material. The blood was collected from the heart in heparinized vials for metal estimation. A part of the tissue was homogenized in ice cold 0.25 M sucrose to obtain 10% (w/v) homogenate for biochemical assays. The control values were pooled.
Biochemical assays: Standard procedures were used for determining the activities of aniline hydroxylase,6) aminopyrine-N-demethylase7) and glutathione-Stransferase8) in liver and glutamic oxalacetic transaminase,9) acid phosphatase") and lactic dehydrogenase11) in kidneys.
Estimation of chromium:
The chromium content of tissues and blood was estimated following wet acid digestion on an atomic absorption spectrophotometer, Perkin-Elmer 303.12) with Cr irrespective of the valence state. The decrease in the activity of hepatic glutathione-S-transferase was observed on the first day of treatment with Cr+6 which continued to decrease with the duration of exposure, while a significant inhibition could only be observed at day 14 of treatment with Cr+3 (Table 1) . The activities of renal glutamic oxalacetic transaminase (GOT), acid phosphatase (AP) and lactic dehydrogenase (LDH) were inhibited significantly in animals treated with Cr+3, while all the renal enzymes remained practitally unaffected in (Table 2 ). The hepatic concentration of Cr increased significantly both at day 7 and 14, while the renal concentration of Cr increased significantly only at day 14 of treatment with Cr+3 or Cr+6. The blood level of Cr increased consistently with duration of treatment from the first day, irrespective of valence state of the metal. The liver and blood uptake of Cr was apparently more marked in animals exposed to Cr+6 than in those exposed to Cr+3 (Table 3) 
